GENinCode Plc (LON:GENI – Get Free Report) was up 2.9% on Thursday . The company traded as high as GBX 4 ($0.05) and last traded at GBX 3.91 ($0.05). Approximately 54,995 shares traded hands during mid-day trading, a decline of 72% from the average daily volume of 193,609 shares. The stock had previously closed at GBX 3.80 ($0.05).
GENinCode Stock Up 2.9 %
The stock’s fifty day moving average price is GBX 4.07 and its 200-day moving average price is GBX 5.58. The company has a market capitalization of £6.92 million, a price-to-earnings ratio of -78.20 and a beta of 0.66. The company has a quick ratio of 15.89, a current ratio of 2.60 and a debt-to-equity ratio of 9.27.
GENinCode Company Profile
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies.
Featured Articles
- Five stocks we like better than GENinCode
- What is the Euro STOXX 50 Index?
- Top 3 Investment Themes to Watch for in 2025
- How to buy stock: A step-by-step guide for beginners
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- The 3 Best Retail Stocks to Shop for in August
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
